A conversation on patient-reported outcomes and the occurrence of adverse events leads the managed care stakeholders into a discussion about the measures used to evaluate the overall performance status of a patient.
Michael Kolodziej, MD, explains that physician assessment of patient performance status is a poor surrogate for a patient’s actual performance status, and measures that help physicians ask the right questions and incorporate the needs of their patients during patient-physician interactions need to be established.
Brian Kiss, MD, agrees with Dr Kolodziej and discusses how the establishment of measures can also have a positive influence on the overall healthcare reimbursement process. Dr Kiss explains that currently, the measures that are used by health plans for reimbursement purposes don’t correlate well with patient-centered outcomes. He adds that payers need better measurement tools to effectively assess care and assign payment to high-quality care.
Although there are many challenges to the development of measures that correlate well with outcomes, Dr Kiss and Ted Okon, MBA, explain that a few do exist and are currently being incorporated into regular practice.
Mr Okon highlights Dr Barbara L. McAneny’s COME HOME program, which is supported by a grant from the Centers for Medicare & Medicaid Innovation. This program has implemented a community oncology medical home model in 7 practices across the country; it is hoped that this model will help improve health outcomes, enhance patient care experiences, and significantly reduce costs of care. Mr Okon adds that 19 measures of quality and value are already being incorporated into electronic medical record systems.
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More